APPRECIATE (Apremilast Clinical Treatment Experience in Psoriasis): A Multi-center, Retrospective Observational Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice
Phase of Trial: Phase IV
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms APPRECIATE
- Sponsors Celgene Corporation
- 03 Nov 2016 Planned End Date changed from 1 Nov 2016 to 1 May 2017.
- 03 Nov 2016 Planned primary completion date changed from 1 Nov 2016 to 1 May 2017.
- 03 Nov 2016 Status changed from not yet recruiting to recruiting.